HHS seeks applications for Amyotrophic Lateral Sclerosis Intermediate Patient Population Expanded Access
Grants
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-09-24
Bailey Malota
WASHINGTON, Sept. 24 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, has announced a funding opportunity aimed at expanding access to clinical trials for patients with amyotrophic lateral sclerosis (ALS). The initiative, titled Amyotrophic Lateral Sclerosis Intermediate Patient Population Expanded Access (U01 Clinical Trial Required), is designed to facilitate greater participation in clinical trials for individuals who are not typically eligible d . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Sept. 24 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, has announced a funding opportunity aimed at expanding access to clinical trials for patients with amyotrophic lateral sclerosis (ALS). The initiative, titled Amyotrophic Lateral Sclerosis Intermediate Patient Population Expanded Access (U01 Clinical Trial Required), is designed to facilitate greater participation in clinical trials for individuals who are not typically eligible d . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com